✦ LIBER ✦

Eribulin mesylate (halichondrin B analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer : A 2-cohort, phase 2 study

✍ Scribed by Martee L. Hensley; Sara Kravetz; Xiaoyu Jia; Alexia Iasonos; William Tew; Lauren Pereira; Paul Sabbatini; Christin Whalen; Carol A. Aghajanian; Corinne Zarwan; Suzanne Berlin

Book ID: 112066910
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 892 KB
Volume: 118
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26569

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 1b-2a study to reverse platinum re

Phase 1b-2a study to reverse platinum resistance through use of a hypomethylating agent, azacitidine, in patients with platinum-resistant or platinum-refractory epithelial ovarian cancer

✍ Siqing Fu; Wei Hu; Revathy Iyer; John J. Kavanagh; Robert L. Coleman; Charles F. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 1 views

A multicenter phase II study of the cryp

A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer

✍ G D’AGOSTINO; J DEL CAMPO; B MELLADO; M.A. IZQUIERDO; T MINARIK; L 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

Phase 2 Study of TLK286 (GST P1-1 Activa

Phase 2 Study of TLK286 (GST P1-1 Activated Glutathione Analog) in patients with platinum and paclitaxel refractory/resistant advanced epithelial ovarian cancer

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 265 KB

Intravenous aflibercept in patients with

Intravenous aflibercept in patients with platinum-resistant, advanced ovarian cancer: Results of a randomized, double-blind, phase 2, parallel-arm study

✍ Tew, William P.; Colombo, Nicoletta; Ray-Coquard, Isabelle; del Campo, Josep M.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

Combined weekly topotecan and biweekly b

Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer : Results of a Phase 2 Study

✍ Kathryn F. McGonigle; Howard G. Muntz; Jacqueline Vuky; Pamela J. Paley; Dan S. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 278 KB

Multi-institutional phase 2 study of TLK

Multi-institutional phase 2 study of TLK286 (TELCYTA™, a glutathione S-transferase P1-1 activated glutathione analog prodrug) in patients with platinum and paclitaxel refractory or resistant ovarian cancer

✍ J.J. KAVANAGH; D.M. GERSHENSON; H. CHOI; L. LEWIS; K. PATEL; G.L. BROWN; A. GARC 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB